Trials / Completed
CompletedNCT04186442
Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder
A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase I Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Hugel · Industry
- Sex
- Female
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
To determine the efficacy and safety of Botulax® in treatment of Overactive Bladder
Detailed description
A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase I Clinical Trial to Compare the Safety and Efficacy of Botulax® versus Botox® in Patient with Overactive Bladder
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum toxin type A injection | Experimental |
| DRUG | Botulinum Toxin Type A Injection [Botox] | Active Comparator |
Timeline
- Start date
- 2020-05-12
- Primary completion
- 2021-04-26
- Completion
- 2021-10-26
- First posted
- 2019-12-04
- Last updated
- 2022-04-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04186442. Inclusion in this directory is not an endorsement.